Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ISONIAZID\RIFAMPIN Cause Muscular weakness? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Muscular weakness have been filed in association with ISONIAZID\RIFAMPIN. This represents 0.8% of all adverse event reports for ISONIAZID\RIFAMPIN.

5
Reports of Muscular weakness with ISONIAZID\RIFAMPIN
0.8%
of all ISONIAZID\RIFAMPIN reports
0
Deaths
2
Hospitalizations

How Dangerous Is Muscular weakness From ISONIAZID\RIFAMPIN?

Of the 5 reports, 2 (40.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Muscular weakness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ISONIAZID\RIFAMPIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ISONIAZID\RIFAMPIN Cause?

Hepatocellular injury (51) Hepatic cytolysis (46) Pyrexia (35) Vomiting (35) Condition aggravated (29) Nausea (26) Neutropenia (26) Off label use (26) Cholestasis (25) Drug reaction with eosinophilia and systemic symptoms (24)

What Other Drugs Cause Muscular weakness?

ADALIMUMAB (3,605) METHOTREXATE (2,813) RITUXIMAB (2,621) ATORVASTATIN (2,494) PREDNISONE (2,236) ETANERCEPT (2,207) DALFAMPRIDINE (1,916) TOCILIZUMAB (1,790) FINGOLIMOD (1,769) SECUKINUMAB (1,747)

Which ISONIAZID\RIFAMPIN Alternatives Have Lower Muscular weakness Risk?

ISONIAZID\RIFAMPIN vs ISOPROPANOLAMINE ISONIAZID\RIFAMPIN vs ISOPROPYL ALCOHOL ISONIAZID\RIFAMPIN vs ISOPROPYL ALCOHOL\LEUPROLIDE ISONIAZID\RIFAMPIN vs ISOPROPYL ALCOHOL\LEUPROLIDE\NORETHINDRONE ISONIAZID\RIFAMPIN vs ISOPROTERENOL

Related Pages

ISONIAZID\RIFAMPIN Full Profile All Muscular weakness Reports All Drugs Causing Muscular weakness ISONIAZID\RIFAMPIN Demographics